Publications by authors named "Werner Meier"

Claim this Profile
R
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis.
Fabian Trillsch, Bastian Czogalla, Sven Mahner, Verena Loidl, Alexander Reuss, Werner Meier

Int J Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.
Dominik Denschlag, Florian Heitz, Jacobus Pfisterer, Darja Tutschkow, Alexander Reuss, Werner Meier

Int J Gynecol Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
Jacobus Pfisterer, Florence Joly, Gunnar Kristensen, Joern Rau, Sven Mahner, Werner Meier, Martina Gropp-Meier

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in : results of the observational AGO-TR1 study (NCT02222883).
Jan Hauke, Philipp Harter, Corinna Ernst, Alexander Burges, Sandra Schmidt, Werner Meier

J Med Genet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
Philipp Harter, Jalid Sehouli, Ignace Vergote, Gwenael Ferron, Alexander Reuss, Werner Meier

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study.
Linn Woelber, Mareike Bommert, Philipp Harter, Katharina Prieske, Christine Zu Eulenburg, Werner Meier

Ann Surg Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy.
Angelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, Rebecca Asher, Manuel Rodrigues, Werner Meier

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Linn Woelber, Katharina Prieske, Christine Eulenburg, Leticia Oliveira-Ferrer, Nikolaus de Gregorio, Werner Meier

Am J Obstet Gynecol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
Katharina Prieske, Linn Woelber, Mustafa Zelal Muallem, Christine Eulenburg, Julia Kathrin Jueckstock, Werner Meier

Gynecol Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?
Linn Woelber, Mareike Bommert, Katharina Prieske, Inger Fischer, Christine Zu Eulenburg, Werner Meier

Geburtshilfe Frauenheilkd· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study.
Rudiger Klapdor, Peter Hillemanns, Linn Wölber, Julia Jückstock, Felix Hilpert, Werner Meier

Int J Gynecol Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group.
Ulrich Canzler, Hans-Joachim Lück, Petra Neuser, Jalid Sehouli, Alexander Burges, Martina Gropp-Meier, Werner Meier

Arch Gynecol Obstet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Jacobus Pfisterer, Catherine M Shannon, Klaus Baumann, Joern Rau, Philipp Harter, Werner Meier

Lancet Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
Jan Hauke, Eric Hahnen, Stephanie Schneider, Alexander Reuss, Lisa Richters, Werner Meier

J Med Genet· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Ignace Vergote, Giovanni Scambia, David M O'Malley, Ben Van Calster, Sang-Yoon Park, Werner Meier

Lancet Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.
Philipp Harter, Jalid Sehouli, Domenica Lorusso, Alexander Reuss, Ignace Vergote, Werner Meier

N Engl J Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the evidence for lymphadenectomy in presumed early ovarian cancer?
Barbara Schmalfeldt, Christine Brambs, Alexander Burges, Ahmed El-Balat, Günter Emons, Martina Gropp-Meier, Werner Meier

Arch Gynecol Obstet· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
Michael Friedlander, Ursula Matulonis, Charlie Gourley, Andreas du Bois, Ignace Vergote, Werner Meier

Br J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Panel of Rabbit Monoclonal Antibodies and Their Diverse Applications Including Inhibition of Epsilon Toxin Oligomerization.
Jennifer R Linden, Kiel Telesford, Samantha Shetty, Paige Winokour, Sylvia Haigh, Werner Meier

Antibodies (Basel)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Werner Meier

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
Rüdiger Klapdor, Peter Hillemanns, Linn Wölber, Julia Jückstock, Felix Hilpert, Werner Meier

Ann Surg Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.
Linn Woelber, Lis-Femke Griebel, Christine Eulenburg, Jalid Sehouli, Julia Jueckstock, Werner Meier

Eur J Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Werner Meier

Lancet Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7).
Philipp Harter, Jalid Sehouli, Alexander Reuss, Klaus Baumann, Lars Hanker, Martina Gropp-Meier, Werner Meier

Int J Gynecol Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Werner Meier

Br J Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis